Vinva Investment Management Ltd Has $6.42 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Vinva Investment Management Ltd increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.5% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 15,247 shares of the company’s stock after purchasing an additional 2,493 shares during the period. Vinva Investment Management Ltd’s holdings in HCA Healthcare were worth $6,418,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Clearstead Trust LLC increased its holdings in shares of HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after acquiring an additional 53 shares during the last quarter. Harbor Capital Advisors Inc. increased its holdings in shares of HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth about $40,000. Compound Global Advisors LLC acquired a new position in HCA Healthcare in the 3rd quarter valued at about $44,000. Finally, True Wealth Design LLC lifted its position in HCA Healthcare by 179.5% during the third quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after acquiring an additional 70 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst sentiment and research upgrades: several outlets and analysts continue to rate HCA favorably — one consensus snapshot called the stock a “Moderate Buy,” reflecting continued analyst confidence that HCA can grow earnings and return capital to shareholders. Article Title
• Positive Sentiment: Long-term demographic bull case: MarketBeat argues HCA is a likely beneficiary of U.S. aging demographics, noting management’s strong guidance (FY2026 EPS and EBITDA ranges), expanded capex, a $10B repurchase authorization and a raised dividend — all supportive of long‑term growth and shareholder returns. Article Title
• Neutral Sentiment: Analyst estimate tweaks from Zacks: Zacks Research nudged near‑term EPS estimates slightly higher for Q2, Q3 and Q4 2026 and raised FY2026 to $29.63, which supports the earnings outlook, but it kept a “Hold” rating — a modest positive but not a strong endorsement. Article Title
• Neutral Sentiment: Zacks’ view is mixed farther out: while FY2026 estimates were lifted, Zacks trimmed its FY2028 EPS forecast modestly — a sign analysts see near‑term strength but some uncertainty on longer‑term margin expansion. Article Title
• Neutral Sentiment: Local/industry headlines are mixed and mostly non‑company specific: a local hospital (Manchester’s Catholic Medical Center) plans to end outpatient mental‑health services and a leadership hire at Methodist Healthcare were reported — signals about regional capacity and staffing but with limited direct impact on HCA’s large national footprint. Article Title Article Title
• Negative Sentiment: Near‑term policy and revenue risks remain prominent: recent company commentary and market writeups note revenue growth was slightly below expectations in the prior quarter and management flagged $600–$900M of potential EBITDA headwinds from insurance‑exchange changes plus state supplemental payment declines — factors that could cap near‑term upside despite strong EPS. Article Title

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president owned 44,379 shares in the company, valued at approximately $22,411,395. The trade was a 8.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 15,214 shares of company stock valued at $7,797,595 in the last quarter. 1.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on HCA shares. Oppenheimer increased their target price on HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft upped their price objective on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Zacks Research cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Jefferies Financial Group raised their price target on shares of HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, KeyCorp set a $503.00 target price on shares of HCA Healthcare in a research report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $534.50.

HCA Healthcare Price Performance

Shares of HCA opened at $533.63 on Monday. The company has a market cap of $119.33 billion, a P/E ratio of 18.80, a P/E/G ratio of 1.64 and a beta of 1.34. The firm has a 50 day simple moving average of $500.34 and a two-hundred day simple moving average of $465.79. HCA Healthcare, Inc. has a one year low of $310.18 and a one year high of $552.90.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period in the prior year, the company earned $6.22 EPS. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s payout ratio is currently 10.15%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.